Xu, J., Shetty, P. B., Feng, W., Chenault, C., Bast, R. C., Hilsenbeck, S. G., & Yu, Y. (2012). Methylation of HIN-1, RASSF1A, RIL and CDH13 in breast cancer is associated with clinical characteristics, but only RASSF1A methylation is associated with outcome. BioMed Central.

Xu, Jia, Priya B. Shetty, Weiwei Feng, Carol Chenault, Robert C. Bast, Susan G. Hilsenbeck, a Yinhua Yu. Methylation of HIN-1, RASSF1A, RIL and CDH13 in Breast Cancer Is Associated With Clinical Characteristics, but Only RASSF1A Methylation Is Associated With Outcome. BioMed Central, 2012.

Xu, Jia, et al. Methylation of HIN-1, RASSF1A, RIL and CDH13 in Breast Cancer Is Associated With Clinical Characteristics, but Only RASSF1A Methylation Is Associated With Outcome. BioMed Central, 2012.